251 related articles for article (PubMed ID: 17579047)
21. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
Takács K; Chandler P; Altmann DM
Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
[TBL] [Abstract][Full Text] [Related]
22. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E
J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670
[TBL] [Abstract][Full Text] [Related]
23. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis.
Brod SA; Khan M; Kerman RH; Pappolla M
J Neuroimmunol; 1995 Apr; 58(1):61-9. PubMed ID: 7537281
[TBL] [Abstract][Full Text] [Related]
24. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
[TBL] [Abstract][Full Text] [Related]
25. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: enhanced in vivo potency of encephalitogenic peptides.
Falk K; Rötzschke O; Santambrogio L; Dorf ME; Brosnan C; Strominger JL
J Exp Med; 2000 Feb; 191(4):717-30. PubMed ID: 10684863
[TBL] [Abstract][Full Text] [Related]
26. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice.
Mokhtarian F; McFarlin DE; Raine CS
Nature; 1984 May 24-30; 309(5966):356-8. PubMed ID: 6203039
[TBL] [Abstract][Full Text] [Related]
27. Amelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms.
Stern JN; Illés Z; Reddy J; Keskin DB; Sheu E; Fridkis-Hareli M; Nishimura H; Brosnan CF; Santambrogio L; Kuchroo VK; Strominger JL
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11743-8. PubMed ID: 15292514
[TBL] [Abstract][Full Text] [Related]
28. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation.
Tsunoda I; Kuang LQ; Igenge IZ; Fujinami RS
J Neuroimmunol; 2005 Mar; 160(1-2):122-34. PubMed ID: 15710465
[TBL] [Abstract][Full Text] [Related]
29. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
Imler TJ; Petro TM
Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
[TBL] [Abstract][Full Text] [Related]
30. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
[TBL] [Abstract][Full Text] [Related]
31. Adoptively transferred experimental autoimmune encephalomyelitis in SJL/J, PL/J, and (SJL/J x PL/J)F1 mice. Influence of I-A haplotype on encephalitogenic epitope of myelin basic protein.
McCarron R; McFarlin DE
J Immunol; 1988 Aug; 141(4):1143-9. PubMed ID: 3260919
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
34. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
Yin LL; Lin LL; Zhang L; Li L
Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
[TBL] [Abstract][Full Text] [Related]
35. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
Tran EH; Hoekstra K; van Rooijen N; Dijkstra CD; Owens T
J Immunol; 1998 Oct; 161(7):3767-75. PubMed ID: 9759903
[TBL] [Abstract][Full Text] [Related]
36. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
Lees JR; Iwakura Y; Russell JH
J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
[TBL] [Abstract][Full Text] [Related]
37. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice.
Kono DH; Urban JL; Horvath SJ; Ando DG; Saavedra RA; Hood L
J Exp Med; 1988 Jul; 168(1):213-27. PubMed ID: 2456367
[TBL] [Abstract][Full Text] [Related]
38. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit.
Costa GL; Sandora MR; Nakajima A; Nguyen EV; Taylor-Edwards C; Slavin AJ; Contag CH; Fathman CG; Benson JM
J Immunol; 2001 Aug; 167(4):2379-87. PubMed ID: 11490028
[TBL] [Abstract][Full Text] [Related]
39. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.
Nath N; Giri S; Prasad R; Singh AK; Singh I
J Immunol; 2004 Jan; 172(2):1273-86. PubMed ID: 14707106
[TBL] [Abstract][Full Text] [Related]
40. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
Sewell DL; Reinke EK; Co DO; Hogan LH; Fritz RB; Sandor M; Fabry Z
Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
